NL-OMON34751
Withdrawn
Not Applicable
A pilot study on symptomatic treatment of uncomplicated urinary tract infections in general practice. - Symptomatic treatment of uncomplicated urinary tract infections.
niversitair Medisch Centrum Utrecht0 sites100 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- bladder infection
- Sponsor
- niversitair Medisch Centrum Utrecht
- Enrollment
- 100
- Status
- Withdrawn
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Women, 18\-45 years of age
- •\- Symptoms and diagnosis of UTI, according to the \*NHG\-standaard\* (symptoms: painful or burning micturition (dysuria), frequency, urgency, hematuria, suprapubic pain).
- •\- Who have provided written informed consent to participate
Exclusion Criteria
- •Immunocompromised patients; pregnancy; diabetes mellitus; a known urological or nephrological disorder; fever, i.e. temperature above 38°C (axillary); pain in back and\-or loin (kidney region); recurrent urinary tract infections (more than three occurrences per year during the past year or a UTI in the past three months); gynaecological complaints \- such as abnormal vaginal discharge, labial irritation, intermittent vaginal bleeding; symptoms present for more than three days; taken antibiotics in the past four weeks.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
A research study for treatment of mild to moderate ulcerative colitis with ayurvedic drugs and comparison with Allopathic treatmentHealth Condition 1: K518- Other ulcerative colitisCTRI/2024/05/067117Dept of Shalya Tantra
Active, not recruiting
Phase 1
Pilot study to assess the efficacy of treatment with metformin in patients with Hidradenitis suppurativa refractory to standard treatmentEUCTR2016-002714-45-ESInstituto de Investigación Sanitaria Fundación Jiménez Díaz
Active, not recruiting
Not Applicable
A phase II study for the treatment of patients with splenic marginal lymphoma with the combination of Cyclophosfamide, Vincristine, Liposomal Doxorubicin, Predinisone and RituximabTreatment of patients with newly diagnosed splenic marginal non Hodgkin lymphomaMedDRA version: 9.1Level: LLTClassification code 10062113Term: Splenic marginal zone lymphomaEUCTR2005-000693-45-ITG.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI
Recruiting
Not Applicable
Pilot study of multimodality treatment based on a new risk stratification in patients with medulloblastomaJPRN-UMIN000014488Japanese Pediatric Brain Tumor Consortium30
Active, not recruiting
Not Applicable
Treatment of Carpal tunnel syndrome symptoms with Nucleo CMP ForteCarpal Tunnel Syndrome (CTS)MedDRA version: 17.0Level: LLTClassification code 10052414Term: Unilateral carpal tunnel syndromeSystem Organ Class: 100000004852Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2014-003272-23-ESDr. Jordi Montero Homs- Unidad de Neuromuscular- Servicio de Neurología- Hospital Universitario de Bellvitge